This Phase 3 study aims to evaluate the efficacy and safety of NTLA-2002 compared to placebo in adult participants with HAE.
Age: 18 years - 66+
Gender: All
We've found 1 total result for "Angioedemas Hereditary".
We've found 1 total result for "Angioedemas Hereditary".
This Phase 3 study aims to evaluate the efficacy and safety of NTLA-2002 compared to placebo in adult participants with HAE.
Age: 18 years - 66+
Gender: All